Great work @RoyalFreeNHS for recruiting our 20th (now 21st) patient to the @CirrhoCareTrial! #healthTech@CyberLiver
Anecdotal learning so far:
1️⃣ Patients seem sad when they have to return the kit at the end!
2️⃣ Older patients and those with active ETOH are engaging well!
By 2030, liver disease is expected to become one of the top three health concerns in the UK, a challenge intensified by the shortfall in specialist care. On #WorldLiverDay we aim to address these challenges through our #DigitalMedicineDevice platform. @DHealthLDN thank you😊
1.5 billion people live with chronic liver disease, and 2 million lives are lost yearly. Early prevention can save many of these lives. We are are working on #DigitalMedicineDevices which could halt, reverse or manage liver disease. #WorldLiverDay#livertwitter
🚨 𝔻𝕚𝕧𝕖𝕣𝕤𝕚𝕥𝕪 𝕒𝕟𝕕 𝕚𝕟𝕔𝕝𝕦𝕤𝕚𝕠𝕟 𝕚𝕟 𝕡𝕒𝕥𝕚𝕖𝕟𝕥 𝕔𝕒𝕣𝕖 𝕒𝕣𝕖 𝕦𝕡 𝕗𝕠𝕣 𝕕𝕚𝕤𝕔𝕦𝕤𝕤𝕚𝕠𝕟 𝕟𝕖𝕩𝕥. How can technology assist? Ask our experts to know more and how we are making a difference.
#BASL2023 🚨 #BASL#DigitalMedicine#LiverDisease
Following the @CirrhoCare study, we demonstrate that fat mass could be an important digital nutritional biomarker in decompensated cirrhosis! https://t.co/OW1fi08ccQ.
Looking forward to validating these findings in the upcoming RCT! @rajmookerjee@CyberLiver#digitalhealth
Every 3⃣0⃣ seconds⏲️, someone loses their battle with viral hepatitis, resulting in 1.34 million worldwide deaths each year.🌍Today, 28 July 2023, on #WorldHepatitisDay let's raise awareness and drive the change against viral hepatitis. @EASLnews@Hep_Alliance@HEP_org@NO_hep ⚕️
Proud to be one of the 8 finalists to pitch our digital medicine platform for the treatment of advanced liver disease at 42plus1 startup pitch competition at #DxPx conference.
Fingers crossed🤞 & we're backing our CEO @rkumar for a home run ⚾️
@DxPx_Conference